Top

Breast Cancer Research and Treatment

Published in:

Open Access 01-01-2019 | Epidemiology

Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics

Authors: Jin-Xiao Ren, Yue Gong, Hong Ling, Xin Hu, Zhi-Ming Shao

Published in: Breast Cancer Research and Treatment | Issue 1/2019

Abstract

Purpose

Population-based estimates of racial disparities in metastatic breast cancer are lacking. We quantified the contributions of demographic, socioeconomic, tumor, and metastatic characteristics to racial differences in metastatic breast cancer and characterized the most disproportional subgroup.

Methods

Patients diagnosed with metastatic breast cancer between 2010 and 2014 were identified using the Surveillance, Epidemiology, and End Results database. A multivariable Cox proportional hazards model was used to adjust each set of variables. The excess relative risk of cancer-specific and all-cause death in non-Hispanic black (NHB) versus non-Hispanic white women diagnosed with metastatic breast cancer was expressed as a percentage and was stratified by the age at diagnosis.

Results

We identified 13,066 female patients. NHB women exhibited substantially higher morbidity and mortality than women of other races/ethnicities. The greatest excess mortality risk for NHB women was observed in the young-onset group (18–49 years; hazard ratio: 1.57), followed by the middle-age group (50–64 years; hazard ratio: 1.42); the trend was not significant among the elderly group. Socioeconomic factors stably explained one-half of the excess risk, whereas the contribution of tumor characteristics obviously decreased with age (18–49 years, 40.7%; 50–64 years, 33.9%), and the metastatic pattern accounted for approximately one-tenth of the excess risk. Additionally, the disproportional death burden of NHB women persisted in less aggressive subgroups.

Conclusions

By providing a comprehensive assessment of racial differences in the incidence and outcomes of patients with metastatic breast cancer, we urge the implementation of targeted preventive efforts in both the public health and clinical arenas.

Available only for authorised users

DeSantis CE, Ma J, Goding Sauer A et al (2017) Breast cancer statistics, 2017, racial disparity in mortality by state. CA 67:439–448. https://doi.org/10.3322/caac.21412 CrossRefPubMed

DeSantis CE, Fedewa SA, Goding Sauer A et al (2016) Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA 66:31–42. https://doi.org/10.3322/caac.21320 CrossRefPubMed

Sighoko D, Hunt BR, Irizarry B et al (2018) Disparity in breast cancer mortality by age and geography in 10 racially diverse US cities. Cancer Epidemiol 53:178–183. https://doi.org/10.1016/j.canep.2018.02.003 CrossRefPubMedPubMedCentral

Stapleton SM, Oseni TO, Bababekov YJ et al (2018) Race/ethnicity and age distribution of breast cancer diagnosis in the United States. JAMA Surg. https://doi.org/10.1001/jamasurg.2018.0035 CrossRefPubMedPubMedCentral

Arciero CA, Yang J, Peng L et al (2017) African American patients with breast cancer have worse prognosis than white patients in certain subtypes and stages. Breast Cancer Res Treat 166:743–755. https://doi.org/10.1007/s10549-017-4484-1 CrossRefPubMed

Vaz-Luis I, Lin NU, Keating NL et al (2015) Racial differences in outcomes for patients with metastatic breast cancer by disease subtype. Breast Cancer Res Treat 151:697–707. https://doi.org/10.1007/s10549-015-3432-1 CrossRefPubMed

Singh GK, Jemal A (2017) Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950–2014: over six decades of changing patterns and widening inequalities. J Environ Public Health 138:1–19. https://doi.org/10.1155/2017/2819372 CrossRef

Jemal A, Robbins AS, Lin CC et al (2018) Factors that contributed to black-white disparities in survival among nonelderly women with breast cancer between 2004 and 2013. J Clin Oncol 36:14–24. https://doi.org/10.1200/JCO.2017.73.7932 CrossRefPubMed

Ellis L, Canchola AJ, Spiegel D et al (2017) Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics. J Clin Oncol. https://doi.org/10.1200/JCO.2017.74.2049 CrossRefPubMedPubMedCentral

10.

Daly B, Olopade OI (2015) A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA 65:221–238. https://doi.org/10.3322/caac.21271 CrossRefPubMed

11.

Surveillance Research Program, National Cancer Institute SEER*Stat software (http://www.seer.cancer.gov/seerstat) version 8.3.5

12.

Surveillance, Epidemiology, and End Results (SEER) Program (2017) (http://www.seer.cancer.gov) SEER*stat database: incidence—SEER 18 Regs excluding AK (with additional treatment fields), Nov 2017 Sub (2000–2015) < Vintage 2015 pops by race/origin tract 2000/2010 mixed geographies>—linked to census tract attributes—time dependent (2000–2015)—SEER 18 (excl AK) Census 2000/2010 Geographies with Index Field Quantiles, National Cancer Institute, DCCPS, Surveillance Research Program, released June 2018, based on the November 2017 submission.

13.

Kish JK, Yu M, Percy-Laurry A (2014) Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) Registries. J Natl Cancer Inst 2014:236–243. https://doi.org/10.1093/jncimonographs/lgu020 CrossRef

14.

Yost K, Perkins C, Cohen R et al (2001) Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12:703–711CrossRef

15.

Surveillance, Epidemiology, and End Results (SEER) Program (2018) (http://www.seer.cancer.gov) SEER*stat database: incidence-based mortality—SEER 18 Regs (Excl Louisiana) Research Data, Nov 2017 Sub (2000–2015) < Katrina/Rita Population Adjustment>—Linked to County attributes—total U.S., 1969–2016 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2018, based on the November 2017 submission.

16.

Dignam JJ, Zhang Q (2012) The use and interpretation of competing risks regression models. Clin Cancer Res 18:2301–2308. https://doi.org/10.1158/1078-0432.CCR-11-2097 CrossRefPubMedPubMedCentral

17.

Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509CrossRef

18.

DeSantis CE, Siegel RL Sauer AG et al (2016) Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA 66:290–308. https://doi.org/10.3322/caac.21340 CrossRefPubMed

19.

Moss JL, Liu B, Feuer EJ (2017) Urban/rural differences in breast and cervical cancer incidence: the mediating roles of socioeconomic status and provider density. Women’s Heal Issues 27:683–691. https://doi.org/10.1016/j.whi.2017.09.008 CrossRef

20.

Yin D, Morris C, Allen M et al (2010) Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups? Cancer Causes Control 21:1721–1730. https://doi.org/10.1007/s10552-010-9601-y CrossRefPubMedPubMedCentral

21.

Komenaka IK, Martinez ME, Pennington RE Jr et al (2010) Race and ethnicity and breast cancer outcomes in an underinsured population. J Natl Cancer Inst 102:1178–1187. https://doi.org/10.1093/jnci/djq215 CrossRefPubMed

22.

Pan H, Walker G, Grant S et al (2017) Insurance status and racial disparities in cancer-specific mortality in the United States: a population-based analysis. Cancer Epidemiol Biomark Prev 26:869–875. https://doi.org/10.1158/1055-9965.EPI-16-0976 CrossRef

23.

DeRouen MC, Parsons HM, Kent EE et al (2017) Sociodemographic disparities in survival for adolescents and young adults with cancer differ by health insurance status. Cancer Causes Control 28:841–851. https://doi.org/10.1007/s10552-017-0914-y CrossRefPubMedPubMedCentral

24.

Martínez ME, Anderson K, Murphy JD et al (2016) Differences in marital status and mortality by race/ethnicity and nativity among California cancer patients. Cancer 122:1570–1578. https://doi.org/10.1002/cncr.29886 CrossRefPubMedPubMedCentral

25.

Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295:2492–2502. https://doi.org/10.1001/jama.295.21.2492 CrossRef

26.

Tao L, Chu L, Wang L et al (2016) Occurrence and outcome of de novo metastatic breast cancer by subtype in a large, diverse population. Cancer Causes Control 27:1127–1138. https://doi.org/10.1007/s10552-016-0791-9 CrossRefPubMed

27.

Keegan TH, DeRouen MC, Press DJ et al (2012) Occurrence of breast cancer subtypes in adolescent and young adult women. Breast Cancer Res 14:1–9. https://doi.org/10.1186/bcr3156 CrossRef

28.

Anders D, Deal AM, Miller CR et al (2011) The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer 117:1602–1611. https://doi.org/10.1002/cncr.25746 CrossRefPubMed

29.

Sposto R, Keegan TH, Vigen C et al (2016) The effect of patient and contextual characteristics on racial/ethnic disparity in breast cancer mortality. Cancer Epidemiol Biomark Prev 25:1064–1072. https://doi.org/10.1158/1055-9965.EPI-15-1326 CrossRef

30.

Iqbal J, Ginsburg O, Rochon PA et al (2015) Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA 313:165–173. https://doi.org/10.1001/jama.2014.17322 CrossRefPubMed

31.

Ning J, Peng S, Ueno N et al (2015) Has racial difference in cause-specific death improved in older patients with late-stage breast cancer? Ann Oncol 26:2161–2168. https://doi.org/10.1093/annonc/mdv330 CrossRefPubMedPubMedCentral

32.

Shoemaker ML, White MC, Wu M et al (2018) Differences in breast cancer incidence among young women aged 20–49 years by stage and tumor characteristics, age, race, and ethnicity, 2004–2013. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-018-4699-9 CrossRefPubMedPubMedCentral

33.

Tao L, Gomez SL, Keegan TH et al (2015) Breast cancer mortality in african-american and non-hispanic white women by molecular subtype and stage at diagnosis: a population-based study. Cancer Epidemiol Biomark Prev 24:1039–1045. https://doi.org/10.1158/1055-9965.EPI-15-0243 CrossRef

34.

Warner ET, Tamimi RM, Hughes ME et al (2015) Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol 33:2254–2261. https://doi.org/10.1200/JCO.2014.57.1349 CrossRefPubMedPubMedCentral

35.

Davis MB, Newman LA (2018) Breast cancer disparities how can we leverage genomics to improve outcomes? Surg Oncol Clin N Am 27:217–234. https://doi.org/10.1016/j.soc.2017.07.009 CrossRefPubMed

36.

Rummel L, Shriver E (2017) Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer. Breast Cancer Res Treat 164:593–601. https://doi.org/10.1007/s10549-017-4291-8 CrossRefPubMed

37.

Parada H, Sun X, Fleming JM et al (2017) Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study. Breast Cancer Res 19:131. https://doi.org/10.1186/s13058-017-0914-6 CrossRefPubMedPubMedCentral

38.

Churpek JE, Walsh T, Zheng Y et al (2015) Inherited predisposition to breast cancer among African American women. Breast Cancer Res Treat 149:31–39. https://doi.org/10.1007/s10549-014-3195-0 CrossRefPubMed

39.

Xiong Z, Deng G, Huang X et al (2018) Bone metastasis pattern in initial metastatic breast cancer: a population-based study. Cancer Manag Res 10:287–295. https://doi.org/10.2147/CMAR.S155524 CrossRefPubMedPubMedCentral

40.

Parkes A, Clifton K, Al-Awadhi A et al (2018) Characterization of bone only metastasis patients with respect to tumor subtypes. npj Breast Cancer 4:2. https://doi.org/10.1038/s41523-018-0054-x CrossRefPubMedPubMedCentral

41.

Leone BA, Vallejo CT, Romero AO et al (2017) Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis. Breast Cancer Res Treat 161:537–548. https://doi.org/10.1007/s10549-016-4066-7 CrossRefPubMed

42.

Lee SJ, Park S, Ahn HK et al (2011) Implications of bone-only metastases in breast cancer: favorable preference with excellent outcomes of hormone receptor positive breast cancer. Cancer Res Treat 43:89–95. https://doi.org/10.4143/crt.2011.43.2.89 CrossRefPubMedPubMedCentral

43.

Martin AM, Cagney DN, Catalano PJ et al (2017) Brain metastases in newly diagnosed breast cancer: a population-based study. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2017.0001 CrossRefPubMedPubMedCentral

44.

Kast K, Schoffer O, Link T et al (2017) Trastuzumab and survival of patients with metastatic breast cancer. Arch Gynecol Obstet 296:303–312. https://doi.org/10.1007/s00404-017-4421-x CrossRefPubMed

45.

Gomez S, Behren J, McKinley M et al (2017) Breast cancer in Asian Americans in California, 1988–2013: increasing incidence trends and recent data on breast cancer subtypes. Breast Cancer Res Treat 164:139–147. https://doi.org/10.1007/s10549-017-4229-1 CrossRefPubMedPubMedCentral

46.

Torre LA, Sauer AM, Chen MS Jr et al (2016) Cancer statistics for Asian Americans, Native Hawaiians. 2016: converging incidence in males and females. CA 66:182–202. https://doi.org/10.3322/caac.21335 CrossRefPubMed

47.

Gomez SL, Glaser SL, Horn-Ross PL et al (2014) Cancer research in Asian American, native Hawaiian, and Pacific Islander populations: accelerating cancer knowledge by acknowledging and leveraging heterogeneity. Cancer Epidemiol Biomark Prev 23:2202–2205. https://doi.org/10.1158/1055-9965.EPI-14-0624 CrossRef

48.

Banegas L (2012) Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women. Breast Cancer Res Treat 134:1297–1304. https://doi.org/10.1007/s10549-012-2142-1 CrossRefPubMedPubMedCentral

Title: Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics
Authors: Jin-Xiao Ren
Yue Gong
Hong Ling
Xin Hu
Zhi-Ming Shao
Publication date: 01-01-2019
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 1/2019
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-018-4956-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2019

Male breast cancer: a disease distinct from female breast cancer

Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer

COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer

A synonymous germline variant PALB2 c.18G>T (p.Gly6=) disrupts normal splicing in a family with pancreatic and breast cancers

Correction to: Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer

Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates

Keynote webinar | Spotlight on antibody–drug conjugates in cancer